Trial Profile

Phase I trial investigating the safety, tolerability and pharmacokinetics of intravenous BC 3781

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Apr 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lefamulin (Primary)
Indications Bacterial infections; Community-acquired pneumonia; Respiratory tract infections; Skin and soft tissue infections
Focus Adverse reactions; Pharmacokinetics
Sponsors Nabriva Therapeutics

Most Recent Events

12 Apr 2010 Reference added for Nabriva Therapeutics media release reporting results presented at ECCMID 2010.
11 Apr 2010 Study design, control, and status details updated from abstract presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2010).
10 Feb 2010 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com